Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06164093
Status:
COMPLETED
Last Update Posted:
2023-12-11
First Post:
2023-11-23
Brief Title:
Follow-up Study of Autologous Transplantation of P63 Lung Progenitor Cells for Treatment of Bronchiectasis
Sponsor:
Ruijin Hospital
Organization:
Ruijin Hospital
Organization Data
Organization:
Ruijin Hospital
Class:
OTHER
Study ID:
2023318
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ruijin Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Jieming QU
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Ruijin Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Regend Therapeutics | INDUSTRY |